Global Drugs for Non-small Cell Lung Cancer Market Analysis 2015-2019 and Forecast 2020-2025

  • The global Drugs for Non-small Cell Lung Cancer market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Non-small Cell Lung Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Radiofrequency Ablation (RFA) 

    Radiation Therapy 

    Chemotherapy 

    Targeted Therapies 

    Immunotherapy

    Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

    Bristol-Myers Squibb 

    GlaxoSmithKline 

    Menarini 

    Sanofi 

    Ziopharm Oncology 

    Alchemia 

    Amgen 

    Apotex 

    BioMarin Pharmaceutical 

    CellAct Pharma 

    Cerulean Pharma 

    Cipla 

    Cornerstone Pharmaceuticals 

    Curis 

    CytRx 

    Eli Lilly 

    Exelixis 

    Fresenius Kabi 

    Genentech 

    Hikma Pharmaceuticals 

    Hospira 

    Intas Pharmaceuticals 

    Karyopharm Therapeutics 

    Kyowa Hakko Kirin 

    Ligand Pharmaceuticals

    Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

    Hospital 

    Clinic 

    Others

    Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

    North America (U.S., Canada, Mexico)

    Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

    Asia-Pacific (China, India, Japan, Southeast Asia etc.)

    South America (Brazil, Argentina etc.)

    Middle East & Africa (Saudi Arabia, South Africa etc.)

     

  • With tables and figures helping analyze worldwide market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Table of Content

    1 Industry Overview

    1.1 Drugs for Non-small Cell Lung Cancer Industry

    Figure Drugs for Non-small Cell Lung Cancer Industry Chain Structure
    1.1.1 Overview
    1.1.2 Development of Drugs for Non-small Cell Lung Cancer

    1.2 Market Segment

    1.2.1 Upstream
    Table Upstream Segment of Drugs for Non-small Cell Lung Cancer
    1.2.2 Downstream
    Table Application Segment of Drugs for Non-small Cell Lung Cancer
    Table Global Drugs for Non-small Cell Lung Cancer Market 2015-2025, by Application, in USD Million

    1.3 Cost Analysis


    2 Industry Environment (PEST Analysis)

    2.1 Policy

    2.2 Economics

    2.3 Sociology

    2.4 Technology


    3 Drugs for Non-small Cell Lung Cancer Market by Type

    3.1 By Type

    3.1.1 Radiofrequency Ablation (RFA) 
    Table Major Company List of Radiofrequency Ablation (RFA) 
    3.1.2 Radiation Therapy 
    Table Major Company List of Radiation Therapy 
    3.1.3 Chemotherapy 
    Table Major Company List of Chemotherapy 
    3.1.4 Targeted Therapies 
    Table Major Company List of Targeted Therapies 
    3.1.5 Immunotherapy
    Table Major Company List of Immunotherapy

    3.2 Market Size

    Table Global Drugs for Non-small Cell Lung Cancer Market 2015-2019, by Type, in USD Million
    Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2015-2019, by Type, in USD Million
    Table Global Drugs for Non-small Cell Lung Cancer Market 2015-2019, by Type, in Volume
    Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2015-2019, by Type, in Volume

    3.3 Market Forecast

    Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2025, by Type, in USD Million
    Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2025, by Type, in Volume

    4 Major Companies List

    4.1 Bristol-Myers Squibb  (Company Profile, Sales Data etc.)

    4.1.1 Bristol-Myers Squibb  Profile
    Table Bristol-Myers Squibb  Overview List
    4.1.2 Bristol-Myers Squibb  Products & Services
    4.1.3 Bristol-Myers Squibb  Business Operation Conditions
    Table Business Operation of Bristol-Myers Squibb  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.2 GlaxoSmithKline  (Company Profile, Sales Data etc.)

    4.2.1 GlaxoSmithKline  Profile
    Table GlaxoSmithKline  Overview List
    4.2.2 GlaxoSmithKline  Products & Services
    4.2.3 GlaxoSmithKline  Business Operation Conditions
    Table Business Operation of GlaxoSmithKline  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.3 Menarini  (Company Profile, Sales Data etc.)

    4.3.1 Menarini  Profile
    Table Menarini  Overview List
    4.3.2 Menarini  Products & Services
    4.3.3 Menarini  Business Operation Conditions
    Table Business Operation of Menarini  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.4 Sanofi  (Company Profile, Sales Data etc.)

    4.4.1 Sanofi  Profile
    Table Sanofi  Overview List
    4.4.2 Sanofi  Products & Services
    4.4.3 Sanofi  Business Operation Conditions
    Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.5 Ziopharm Oncology  (Company Profile, Sales Data etc.)

    4.5.1 Ziopharm Oncology  Profile
    Table Ziopharm Oncology  Overview List
    4.5.2 Ziopharm Oncology  Products & Services
    4.5.3 Ziopharm Oncology  Business Operation Conditions
    Table Business Operation of Ziopharm Oncology  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.6 Alchemia  (Company Profile, Sales Data etc.)

    4.6.1 Alchemia  Profile
    Table Alchemia  Overview List
    4.6.2 Alchemia  Products & Services
    4.6.3 Alchemia  Business Operation Conditions
    Table Business Operation of Alchemia  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.7 Amgen  (Company Profile, Sales Data etc.)
    4.7.1 Amgen  Profile
    Table Amgen  Overview List
    4.7.2 Amgen  Products & Services
    4.7.3 Amgen  Business Operation Conditions
    Table Business Operation of Amgen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.8 Apotex  (Company Profile, Sales Data etc.)
    4.8.1 Apotex  Profile
    Table Apotex  Overview List
    4.8.2 Apotex  Products & Services
    4.8.3 Apotex  Business Operation Conditions
    Table Business Operation of Apotex  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.9 BioMarin Pharmaceutical  (Company Profile, Sales Data etc.)
    4.9.1 BioMarin Pharmaceutical  Profile
    Table BioMarin Pharmaceutical  Overview List
    4.9.2 BioMarin Pharmaceutical  Products & Services
    4.9.3 BioMarin Pharmaceutical  Business Operation Conditions
    Table Business Operation of BioMarin Pharmaceutical  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.10 CellAct Pharma  (Company Profile, Sales Data etc.)
    4.10.1 CellAct Pharma  Profile
    Table CellAct Pharma  Overview List
    4.10.2 CellAct Pharma  Products & Services
    4.10.3 CellAct Pharma  Business Operation Conditions
    Table Business Operation of CellAct Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.11 Cerulean Pharma  (Company Profile, Sales Data etc.)
    4.11.1 Cerulean Pharma  Profile
    Table Cerulean Pharma  Overview List
    4.11.2 Cerulean Pharma  Products & Services
    4.11.3 Cerulean Pharma  Business Operation Conditions
    Table Business Operation of Cerulean Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.12 Cipla  (Company Profile, Sales Data etc.)
    4.12.1 Cipla  Profile
    Table Cipla  Overview List
    4.12.2 Cipla  Products & Services
    4.12.3 Cipla  Business Operation Conditions
    Table Business Operation of Cipla  (Sales Revenue, Cost, Gross Margin)
    4.13 Cornerstone Pharmaceuticals  (Company Profile, Sales Data etc.)
    4.13.1 Cornerstone Pharmaceuticals  Profile
    Table Cornerstone Pharmaceuticals  Overview List
    4.13.2 Cornerstone Pharmaceuticals  Products & Services
    4.13.3 Cornerstone Pharmaceuticals  Business Operation Conditions
    Table Business Operation of Cornerstone Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.14 Curis  (Company Profile, Sales Data etc.)
    4.14.1 Curis  Profile
    Table Curis  Overview List
    4.14.2 Curis  Products & Services
    4.14.3 Curis  Business Operation Conditions
    Table Business Operation of Curis  (Sales Revenue, Cost, Gross Margin)
    4.15 CytRx  (Company Profile, Sales Data etc.)
    4.15.1 CytRx  Profile
    Table CytRx  Overview List
    4.15.2 CytRx  Products & Services
    4.15.3 CytRx  Business Operation Conditions
    Table Business Operation of CytRx  (Sales Revenue, Cost, Gross Margin)
    4.16 Eli Lilly  (Company Profile, Sales Data etc.)
    4.16.1 Eli Lilly  Profile
    Table Eli Lilly  Overview List
    4.16.2 Eli Lilly  Products & Services
    4.16.3 Eli Lilly  Business Operation Conditions
    Table Business Operation of Eli Lilly  (Sales Revenue, Cost, Gross Margin)
    4.17 Exelixis  (Company Profile, Sales Data etc.)
    4.17.1 Exelixis  Profile
    Table Exelixis  Overview List
    4.17.2 Exelixis  Products & Services
    4.17.3 Exelixis  Business Operation Conditions
    Table Business Operation of Exelixis  (Sales Revenue, Cost, Gross Margin)
    4.18 Fresenius Kabi  (Company Profile, Sales Data etc.)
    4.18.1 Fresenius Kabi  Profile
    Table Fresenius Kabi  Overview List
    4.18.2 Fresenius Kabi  Products & Services
    4.18.3 Fresenius Kabi  Business Operation Conditions
    Table Business Operation of Fresenius Kabi  (Sales Revenue, Cost, Gross Margin)
    4.19 Genentech  (Company Profile, Sales Data etc.)
    4.19.1 Genentech  Profile
    Table Genentech  Overview List
    4.19.2 Genentech  Products & Services
    4.19.3 Genentech  Business Operation Conditions
    Table Business Operation of Genentech  (Sales Revenue, Cost, Gross Margin)
    4.20 Hikma Pharmaceuticals  (Company Profile, Sales Data etc.)
    4.20.1 Hikma Pharmaceuticals  Profile
    Table Hikma Pharmaceuticals  Overview List
    4.20.2 Hikma Pharmaceuticals  Products & Services
    4.20.3 Hikma Pharmaceuticals  Business Operation Conditions
    Table Business Operation of Hikma Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
    4.21 Hospira  (Company Profile, Sales Data etc.)
    4.21.1 Hospira  Profile
    Table Hospira  Overview List
    4.21.2 Hospira  Products & Services
    4.21.3 Hospira  Business Operation Conditions
    Table Business Operation of Hospira  (Sales Revenue, Cost, Gross Margin)
    4.22 Intas Pharmaceuticals  (Company Profile, Sales Data etc.)
    4.22.1 Intas Pharmaceuticals  Profile
    Table Intas Pharmaceuticals  Overview List
    4.22.2 Intas Pharmaceuticals  Products & Services
    4.22.3 Intas Pharmaceuticals  Business Operation Conditions
    Table Business Operation of Intas Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
    4.23 Karyopharm Therapeutics  (Company Profile, Sales Data etc.)
    4.23.1 Karyopharm Therapeutics  Profile
    Table Karyopharm Therapeutics  Overview List
    4.23.2 Karyopharm Therapeutics  Products & Services
    4.23.3 Karyopharm Therapeutics  Business Operation Conditions
    Table Business Operation of Karyopharm Therapeutics  (Sales Revenue, Cost, Gross Margin)
    4.24 Kyowa Hakko Kirin  (Company Profile, Sales Data etc.)
    4.24.1 Kyowa Hakko Kirin  Profile
    Table Kyowa Hakko Kirin  Overview List
    4.24.2 Kyowa Hakko Kirin  Products & Services
    4.24.3 Kyowa Hakko Kirin  Business Operation Conditions
    Table Business Operation of Kyowa Hakko Kirin  (Sales Revenue, Cost, Gross Margin)
    4.25 Ligand Pharmaceuticals (Company Profile, Sales Data etc.)
    4.25.1 Ligand Pharmaceuticals Profile
    Table Ligand Pharmaceuticals Overview List
    4.25.2 Ligand Pharmaceuticals Products & Services
    4.25.3 Ligand Pharmaceuticals Business Operation Conditions
    Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

    5 Market Competition

    5.1 Company Competition

    Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2015-2019, by Company, in USD Million
    Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share 2015-2019, by Company, in USD Million
    Figure Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share in 2019, by Company, in USD Million
    Table Global Drugs for Non-small Cell Lung Cancer Sales Volume 2015-2019, by Company, in Volume
    Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share 2015-2019, by Company, in Volume
    Figure Global Drugs for Non-small Cell Lung Cancer Sales Volume Share in 2019, by Company, in Volume

    5.2 Regional Market by Company

    Figure North America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2019
    Figure Europe Drugs for Non-small Cell Lung Cancer Market Market Concentration, in 2019
    Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer MMarket Concentration, in 2019
    Figure South America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2019
    Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Concentration, in 2019

    6 Demand by End Market

    6.1 Demand Situation

    6.1.1 Demand in Hospital 
    Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2015-2019, in USD Million
    Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2015-2019, in Volume
    6.1.2 Demand in Clinic 
    Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2015-2019, in USD Million
    Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2015-2019, in Volume
    6.1.3 Demand in Others
    Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2015-2019, in USD Million
    Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2015-2019, in Volume

    6.2 Regional Demand Comparison

    Table Regional Demand Comparison List
    Table Major Application in Different Regions

    6.3 Demand Forecast

    Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2020-2025, by Application, in USD Million
    Figure Drugs for Non-small Cell Lung Cancer Market Growth 2020-2025, by Application, in USD Million
    Figure Drugs for Non-small Cell Lung Cancer Market Share in 2025, by Application, in USD Million
    Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2020-2025, by Application, in Volume
    Table Drugs for Non-small Cell Lung Cancer Market Growth 2020-2025, by Application, in Volume
    Table Drugs for Non-small Cell Lung Cancer Market Share in 2025, by Application, in Volume

    7 Region Operation

    7.1 Regional Production

    Table Drugs for Non-small Cell Lung Cancer Production 2015-2019, by Region, in USD Million
    Table Drugs for Non-small Cell Lung Cancer Production 2015-2019, by Region, in Volume

    7.2 Regional Market

    Table Global Drugs for Non-small Cell Lung Cancer Market 2015-2019, by Region, in USD Million
    Table Global Drugs for Non-small Cell Lung Cancer Market Share 2015-2019, by Region, in USD Million
    Table Global Drugs for Non-small Cell Lung Cancer Market 2015-2019, by Region, in Volume
    Table Global Drugs for Non-small Cell Lung Cancer Market Share 2015-2019, by Region, in Volume

    7.3 by Region

    7.3.1 North America
    7.3.1.1 Overview
    Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in USD Million
    Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
    Table North America Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in USD Million
    Table North America Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in Volume
    7.3.2 Europe
    7.3.2.1 Overview
    Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in USD Million
    Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
    Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in USD Million
    Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in Volume
    7.3.3 Asia-Pacific
    7.3.3.1 Overview
    Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in USD Million
    Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
    Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in USD Million
    Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in Volume
    7.3.4 South America
    7.3.4.1 Overview
    Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in USD Million
    Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
    Table South America Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in USD Million
    Table South America Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in Volume
    7.3.5 Middle East & Africa
    7.3.5.1 Overview
    Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in USD Million
    Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2015-2019, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
    Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in USD Million
    Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2015-2019, by Country, in Volume

    7.4 Regional Import & Export

    7.5 Regional Forecast

    Table Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2025, by Region, in USD Million
    Table Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2025, by Region, in Volume

    8 Marketing & Price

    8.1 Price and Margin

    8.1.1 Price Trends
    8.1.2 Factors of Price Change
    Table Price Factors List
    8.1.3 Manufacturers Gross Margin Analysis

    8.2 Marketing Channel

    Figure Marketing Channels Overview

    9 Research Conclusion

     

  • The Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
Licensing options
2980
USD

Need assistance ?

Research objectives

Where will all these developments take the industry in the long

To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

What are the future opportunities in the market?

To understand the structure of Market by identifying its various subsegments.

What are the major driving forces expected to impact the development of the market market across different regions?

To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

To project the consumption of market submarkets, with respect to key regions.

Who are the major driving forces expected to decide the fate of the industry worldwide.

To strategically profile the key players and comprehensively analyze their growth strategies.

What are the key barriers and threats believed to hinder the development of the industry?

To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

Who are the prominent market players making a mark in the market with their winning strategies?

To share detailed information about the key factors influencing the growth of the market

What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Our Clients